Sonoma Orthopedic Closes Series D Round of Funding

@font-face { font-family: “Times”; }@font-face { font-family: “Cambria”; }p.MsoNormal, li.MsoNormal, div.MsoNormal { margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: “Times New Roman”; }div.Section1 { page: Section1; }

Medtech startup, Sonoma Orthopedic Products recently closed a $22 million Series D financing round led by Ascension Health Ventures (AHV). Also participating in the round were Split Rock Partners, Legacy Life Sciences, EDF Ventures, MedVenture Associates, DFJ InCube Ventures, Emergent Medical Partners, and Asset Management Partners. In connection with the financing, Dr. Walter Lin of AHV has joined Sonoma’s board of directors.

The firm, based in Santa Rosa, Calif., is a trauma company focused on minimally invasive repair of fractured bone through proprietary implant technology. Sonoma, which has developed two implant devices for repairing fractures of the wrist and collarbone, now has raised almost $50 million since it was founded in 2005.

The financing will support several new product launches, expansion of the U.S. sales network, key clinical trials, and the acquisition of certain key assets of NovaLign Orthopaedics, Inc. The company acquired technology for fixing long bone fractures from Tennessee-based NovaLign. Financial terms of the acquisition were not disclosed.

“We are pleased by the level of support provided by Sonoma’s distinguished new and existing investors, who share our vision for advancing the field of minimally invasive fracture repair,” said Glen Coleman, president and CEO of Sonoma Orthopedic Products.

AHV’s Dr. Walter Lin added: “Sonoma’s unique flexible-to-rigid WaviBody and TaperBody platform technologies address a clear clinical need in orthopedic trauma care. We are excited to partner with Sonoma’s experienced management team and board to make its implants more widely available for the benefit of patients.”